Neogen Corp. (NEOG)
11.15
-0.08
(-0.71%)
USD |
NASDAQ |
Mar 02, 16:00
11.16
+0.01
(+0.09%)
After-Hours: 20:00
Neogen Research and Development Expense (Annual) : 21.09M for May 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Teleflex, Inc. | 144.78M |
| AbbVie, Inc. | 8.249B |
| Prestige Consumer Healthcare, Inc. | -- |
| Outlook Therapeutics, Inc. | 27.78M |
| Organon & Co. | 366.00M |